- Diabet Med. 2007 Apr;24(4):333-43. Epub 2007 Mar 15. LinkOut
- Erratum in:
- Diabet Med. 2007 Sep;24(9):1054.
- Comment in:
- Evid Based Med. 2007 Oct;12(5):152.
Bennett CM, Guo M , Dharmage SC .
Department of Public Health, School of Population Health, The University of Melbourne, Australia. email@example.com
AIM: To assess the validity of glycated haemoglobin A(1c) (HbA(1c)) as a screening tool for early detection of Type 2 diabetes. METHODS: Systematic review of primary cross-sectional studies of the accuracy of HbA(1c) for the detection of Type 2 diabetes using the oral glucose tolerance test as the reference standard and fasting plasma glucose as a comparison. RESULTS Nine studies met the inclusion criteria. At certain cut-off points, HbA(1c) has slightly lower sensitivity than fasting plasma glucose (FPG) in detecting diabetes, but slightly higher specificity. For HbA(1c) at a Diabetes Control and Complications Trial and UK Prospective Diabetes Study comparable cut-off point of > or = 6.1%, the sensitivity ranged from 78 to 81% and specificity 79 to 84%. For FPG at a cut-off point of > or = 6.1 mmol/l, the sensitivity ranged from 48 to 64% and specificity from 94 to 98%. Both HbA(1c) and FPG have low sensitivity for the detection of impaired glucose tolerance (around 50%). CONCLUSIONS HbA(1c) and FPG are equally effective screening tools for the detection of Type 2 diabetes. The HbA(1c) cut-off point of > 6.1% was the recommended optimum cut-off point for HbA(1c) in most reviewed studies; however, there is an argument for population-specific cut-off points as optimum cut-offs vary by ethnic group, age, gender and population prevalence of diabetes. Previous studies have demonstrated that HbA(1c) has less intra-individual variation and better predicts both micro- and macrovascular complications. Although the current cost of HbA(1c) is higher than FPG, the additional benefits in predicting costly preventable clinical complications may make this a cost-effective choice.
PMID: 17367307 [PubMed – indexed for MEDLINE]
- [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities] [Ann Acad Med Stetin. 2004]
- Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening. [Diabetes Care. 2003]
- The fasting plasma glucose cut-point predicting a diabetic 2-h OGTT glucose level depends on the phenotype. [Diabetes Res Clin Pract. 2002]
- Is fasting blood glucose a reliable parameter for screening for diabetes in hypertension? [Am J Hypertens. 2003]
- Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study. [Diabetes Care. 2002]
|Display SummaryBriefAbstractAbstractPlusCitation MEDLINEXMLUI ListLinkOutASN.1Related Articles Cited in BooksCancerChrom LinksDomain Links3D Domain Links GEO DataSet LinksGene LinksGene (GeneRIF) LinksGenome Links Project LinksGENSAT LinksGEO Profile LinksHomoloGene LinksCoreNucleotide Links CoreNucleotide (RefSeq) LinksEST LinksEST (RefSeq) Links GSS LinksGSS (RefSeq) LinksNucleotide LinksNucleotide (RefSeq) Links OMIA LinksOMIM (calculated) LinksOMIM (cited) LinksBioAssay Links Compound LinksCompound (MeSH Keyword)Compound (Publisher) LinksSubstance Links Substance (MeSH Keyword)Substance (Publisher) LinksPMC Links Cited in PMCPopSet LinksProbe LinksProtein LinksProtein (RefSeq) Links Protein Cluster LinksCited ArticlesSNP LinksStructure Links Taxonomy via GenBankUniGene LinksUniSTS Links Show 5102050100200500 Sort ByPub Date First AuthorLast AuthorJournal Send toTextFilePrinterClipboardE-mail Order|
2 thoughts on “HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.”